Plateaus are part of the process
With increasing concern over adverse events across the class, liver safety, cardiovascular outcomes, PK and PD stability, and dose optimized adherence will decide which assets rise to best in class status
doi: 10.1038/nn.4574 74 ChenJYCamposCAJarvieBCPalmiterRD
Liraglutide does not alter behavioural markers of ALS in SOD1 G93A transgenic mice Due to the tolerated higher 75 nmol/kg liraglutide dose and the larger effect on blood glucose levels, we dosed SOD1 G93A transgenic mice with vehicle, 25 nmol/kg or 75 nmol/kg liraglutide from 25 to 90 days of age
doi:10.1001/archderm.1922.02360060046004\ Wikipedia contributors, Doctrine of signatures, Wikipedia, The Free Encyclopedia, (accessed August 28, 2024)
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population